InvestorsHub Logo
Followers 33
Posts 2662
Boards Moderated 0
Alias Born 10/28/2013

Re: Astavakra post# 45577

Monday, 11/23/2015 11:25:56 PM

Monday, November 23, 2015 11:25:56 PM

Post# of 739801
Nice thought... but it would be even nicer if excessive efficacy did not prolong a trial. And hopefully AA is the solution to that dilema, if such a dilema exists.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News